Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023 [Yahoo! Finance]
Fulgent Genetics, Inc. (FLGT)
Last fulgent genetics, inc. earnings: 3/10 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.fulgentgenetics.com
Company Research
Source: Yahoo! Finance
GAAP Net Loss: $167.8 million for the full year, equating to $5.63 per share; $128.1 million for Q4, or $4.30 per share. Non-GAAP Income/Loss: Non-GAAP loss of $12.3 million for the full year; income of $8.3 million for Q4. Cash Position: Ended 2023 with $847.7 million in cash, cash equivalents, and marketable securities. Stock Repurchase: Over 953,000 shares repurchased in 2023 at a cost of $25.1 million. 2024 Outlook: Core Revenue projected at approximately $280 million with an anticipated GAAP loss of $2.25 per share. Warning! GuruFocus has detected 3 Warning Sign with FLGT. Fulgent Genetics Inc ( NASDAQ:FLGT ) released its 8-K filing on February 28, 2024, revealing a mix of robust core revenue growth and a significant GAAP net loss for the full year and fourth quarter of 2023. The company, known for its genetic testing services and therapeutic development, reported a year-over-year increase in core revenue, which excludes revenue from COVID-19 testing, showcasing the
Show less
Read more
Impact Snapshot
Event Time:
FLGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLGT alerts
High impacting Fulgent Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
FLGT
News
- Global $5.4 Billion Carrier Screening Market, 2024-2028: Analysis by Product & Service, Type, Technology, Medical Condition, End-user, and Region [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024Business Wire
- Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years [Yahoo! Finance]Yahoo! Finance
- Fulgent Genetics, Inc. (NASDAQ: FLGT) had its price target lowered by analysts at Piper Sandler from $28.00 to $25.00. They now have a "neutral" rating on the stock.MarketBeat
- An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued [Yahoo! Finance]Yahoo! Finance
FLGT
Earnings
- 2/28/24 - Beat
FLGT
Sec Filings
- 3/27/24 - Form ARS
- 3/27/24 - Form DEFA14A
- 3/27/24 - Form DEF
- FLGT's page on the SEC website